(Q83203008)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

main subject

acute myeloid leukemia

1 reference

childhood acute myeloid leukemia

inferred from title

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jeffrey Rubnitz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

Elihu Estey

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Bassem I Razzouk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Shelly Lensing

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sherry Pierce

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Mark Brandt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Raul C Ribeiro

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Michael Rytting

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ching-Hon Pui

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Hagop Kantarjian

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sima Jeha

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

2495-2502

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Clinicopathologic characteristics of leukemia in Japanese children and young adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Allogeneic bone marrow transplantation for children with acute myelocytic leukemia in first remission demonstrates a role for graft versus leukemia in the maintenance of disease-free survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Favorable impact of the t(9;11) in childhood acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

The challenge of acute myeloid leukemia in older patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

The relationship of patient age to the pathobiology of the clonal myeloid diseases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Differences in outcome in adolescents with acute lymphoblastic leukemia: a consequence of better regimens? Better doctors? Both?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Compliance of pediatric and adolescent cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Physician compliance and relapse rates of acute lymphoblastic leukemia in children.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Compliance with oral chemotherapy in childhood lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21892

7 January 2021

Identifiers

DOI

10.1002/CNCR.21892

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16639734%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference